Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950103-23-001416)

Filing Details

Accession Number:: 0000950103-23-001416
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-01-30 19:27:15
Reporting Period:: 2023-01-27

Accepted Time:: 2023-01-30 19:27:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1356090	Precigen Inc.	PGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1947221	R Rutul Shah	C/O Precigen, Inc. 20374 Seneca Meadows Parkway Germantown MD 20876	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-27	9,142	$1.75	62,037	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reporting person purchased shares of Precigen common stock ("Common Stock") in connection with the issuer's follow-on offering, which closed on January 27, 2023. The purchase price is the offering price.